Universal Time: 12:55  |  Local Time: 12:55 (3h GMT)
Select your timezone:

Dealing with post-transplant complications

Tuesday September 24, 2024 - 15:40 to 16:40

Room: Emirgan 1

351.3 Managing post-transplant metabolic disease

Wai Lim, Australia

Medical Director of Kidney Transplant
Sir Charles Gairdner Hospital


Wai Lim is a Senior Consultant Nephrologist at Sir Charles Gairdner Hospital (SCGH) and Clinical Professor of Medicine at the University of Western Australia, Perth, Australia. He is the Chair of the Australia Kidney Trial Network Transplant working group, Committee Member of the Commonwealth-funded National Indigenous Kidney Transplantation Taskforce (NIKTT), Co-Chair of the Scientific Program Education Committee (SPEC) of the Transplantation Society of Australia and New Zealand (TSANZ) and Chair of the Scientific Review Ethics Subcommittee at Sir Charles Gairdner Hospital. There are four key areas of research interests: “Epidemiology and kidney transplantation” with research focusing on improving allocation, identifying factors associated with allograft and patient outcomes in kidney transplant recipients; “Immunology profile and transplant outcome” focusing on the personalised immunological risk profile; “Epidemiology and clinical nephrology” focusing on the impact of nutrition and survival and evaluating biomarkers and cardiovascular disease in patients with chronic kidney disease; and “Clinical trials” focusing on intervention to improve cardiovascular disease in kidney transplant recipients and patients with chronic kidney disease.

Social Media Promotion Image

right-click to download

© 2024 TTS 2024